Form 8-K Atara Biotherapeutics, For: Aug 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Grand Canyon Education places CFO on leave amid stock trade probe
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Funds sell $44bn in semiconductors on AI concerns
ATARA Biotherapeutics (ATRA) Misses Q2 EPS by 18c
August 6, 2015 6:49 AM EDTATARA Biotherapeutics (NASDAQ: ATRA) reported Q2 EPS of ($0.62), $0.18 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.
... More